|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Hantung Chang | Michael Kang | Elaine Chu | (02)2795-1777 | 6F, No28, Ln.36, Xinhu 1st Rd., Neihu Dist.,Taipei City 11494, Taiwan | 2012/09/17 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | GGA Corp is the 1st publicly traded company specializing in genetic diagnosis and scientific informatics in Taiwan.Driven by its commitment to achieve Personal Healthcare from Age Zero,GGA offers a broad array of testing services not only for embryos and fetuses but also newborns,children and adults.GGA has developed diverse testing services ranging from prenatal screening to pharmacogenomics and even to oncology.GGA established its informatics business unit in 2011,and officially entered the high-end scientific informatics market.This BU not only specializes in bioinformatics and computational life sciences,but also in materials sciences,laboratory informatics,as well as enterprise quality management systems. This relentless effort in pursuing excellence is the best testament of GGA’s motto: “Innovation Is in Our DNA. It’s Embedded in Our Corporate Culture and History.” |
Market Information ( 2024/05/03 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
635.11 | 54.70 | 53.10 | 53.20 | -1.50 | 652 | .00 | N/A | N/A | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/05/03) |
TPEx measures adopted (2024/05/03) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |